Advertisement

Der Internist pp 279-284 | Cite as

Antihypertensive Therapie und Compliance

Einfluß von Therapieform und Lebensqualität
  • T. F. Lüscher
Chapter

Zusammenfassung

Die Compliance oder Therapie-treue stellt bei Hypertonie-Patienten bekanntermaßen ein besonderes Problem dar. Dies geht soweit, daß mangelnde Therapietreue in der Langzeittherapie der Hypertonie zum wichtigsten therapielimitierenden Faktor geworden ist. Die vorliegende Übersichtsarbeit faßt das gegenwärtige Wissen über das Ausmaß und die Ursachen mangelnder Therapietreue bzw. Compliance zusammen und geht auf die Wirksamkeit und Praktikabilität von Maßnahmen zur Verbesserung der Medikamenten-Compliance ein.

Schlüsselwörter

Therapietreue Drop-outs Hypertoniker Compliance-bestimmende Faktoren Blutdruckselbstmessung 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Alderman MH, Charlson ME, Melcher LA (1981) Labelling and absenteeism: The Massachusetts mutual experience. Clin Invest Med 4:165PubMedGoogle Scholar
  2. 2.
    Avorn J, Everitt DE, Weiss S (1986) Increased antidepressant use in patients prescribed β-blockers. J Am Med Assoc 255:357CrossRefGoogle Scholar
  3. 3.
    Caldwell JR, Cob S, Dowling MD, de Jongh D (1970) The dropout problem in antihypertensive treatment. J Chron Dis 22:579PubMedCrossRefGoogle Scholar
  4. 4.
    Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams G (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 314:1657PubMedCrossRefGoogle Scholar
  5. 5.
    Degoulet P, Ménard J, Vu HA, Gold-mard JL, Devries C, Chatellier G, Plouin PF (1983) Factors predicting attendance at clinic and blood pressure control in hypertensive patients. Br Med J 287:88CrossRefGoogle Scholar
  6. 6.
    Doherty WJ, Schrott HG, Metcalf L, Lasiello-Vailas L (1983) Effect of spouse support and health beliefs on medication adherence. J Fam Pract 17:837PubMedGoogle Scholar
  7. 7.
    Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee (1984) Hypertension prevalence and the status of awareness, treatment, and control in the Unites States. Hypertension 7:457Google Scholar
  8. 8.
    Fletcher SW, Appel FA, Bourgeois MA (1975) Management of hypertension. Effect of improving compliance for follow-up care. JAMA 233:242PubMedCrossRefGoogle Scholar
  9. 9.
    Foerster E-CH, Achermann R, Groth H, Edmonds D, Siegenthaler W, Vetter W (1985) Verbessert die Blutdruckselbst-messung die Compliance des Hypertonikers? Schweiz Med Wochenschr 115:163PubMedGoogle Scholar
  10. 10.
    Folsom AR, Luepker RV, Gillum RF, Jacobs DR, Prineas RJ, Taylor HL, Blackburn H (1983) Improvement in hypertension detection and control from 1973–1974 to 1980–1981. JAMA 250:916PubMedCrossRefGoogle Scholar
  11. 11.
    Francis V, Korsch BM, Morris MJ (1969) Gaps in doctor-patient communication. N Engl J Med 28:535CrossRefGoogle Scholar
  12. 12.
    Gatley MS (1968) To be taken as directed. JR Coll Gen Pract 16:39Google Scholar
  13. 13.
    Gutzwiller F, Hoffmann A, Alexander J, Brunner HR, Schucan C, Vetter W (1981) Epidemiologie des Blutdruckes in vier Schweizer Städten. Schweiz Med Wochenschr 12:40Google Scholar
  14. 14.
    Haynes RB (1976) A critical review of the ‘determinants’ of patient compliance with therapeutic regimens. In: Sackett DL, Haynes RB (eds) Compliance with therapeutic regimens. Johns Hopkins University Press, Baltimore, p 27Google Scholar
  15. 15.
    Hollenberg NM (1987) Initial therapy in hypertension: Quality- of-life considerations. J Hypertens 5 [Suppl 1]:3Google Scholar
  16. 16.
    Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year findings of the Hypertension Detection and Follow-up Program. JAMA 242:2562CrossRefGoogle Scholar
  17. 17.
    Jachuck SJ, Brierley H, Jachuck S, Willcox PM (1982) The effect of hypotensive drugs on the quality of life. JR Coll Pract 32:103Google Scholar
  18. 18.
    Kannel WB (1970) Framingham study and chronic disease prevention. Hosp Pract 5:78Google Scholar
  19. 19.
    Kleinert HD, Harshfield GA, Pickering TG, Devereux RB, Sullivan PA, Marion RM, Mallory WK, Laragh JH (1984) What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 6:574PubMedCrossRefGoogle Scholar
  20. 20.
    Korsch BM, Negrete VF (1970) Doctor-patient communication. Sci Am 227:66CrossRefGoogle Scholar
  21. 21.
    Ley P (1985) Doctor-patient communication: Some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens 3 [Suppl 1]: 51Google Scholar
  22. 22.
    Lüscher T, Vetter H, Greminger P, Steiner R, Siegenthaler W, Vetter W (1982) Patienten-Compliance. Klin Wochenschr 60:161PubMedCrossRefGoogle Scholar
  23. 23.
    Lüscher T, Dorst KG, Vetter H, Scheu H, Greminger P, Haase W, Vetter W (1982) Compliance-bestimmende Faktoren bei Hypertonikern. Schweiz Med Wochenschr 112:458PubMedGoogle Scholar
  24. 24.
    Lüscher TF, Steiner R, Siegenthaler W, Vetter W (1982) Blutdruckselbstmessung: Anwendung und Stellenwert in der Langzeittherapie von Hypertonikern. Schweiz Rundsch Med Prax 38:1454Google Scholar
  25. 25.
    Lüscher TF, Siegenthaler W, Vetter W (1983) Milde Hypertonie: Hypertonie: Behandeln oder nicht behandeln? Schweiz Rundsch Med Prax 72:1409PubMedGoogle Scholar
  26. 26.
    Lüscher TF, Vetter H, Siegenthaler W, Vetter W (1985) Compliance in hypertension: Facts and concepts. J Hypertens 3 [Suppl 1]: 3Google Scholar
  27. 27.
    Medical Research Council Working Party on Mild-to-Moderate Hypertension (1981) Adverse reactions to bendro-fluazide and propranolol for the treatment of mild hypertension. Lancet 11:539Google Scholar
  28. 28.
    Monk M (1981) Blood pressure awareness and psychological well-being in the health and nutrition examination survey. Clin Invest Med 4:183PubMedGoogle Scholar
  29. 29.
    Neyses L, Dorst K, Michaelis J, Berres M, Philipp T, Distler A, Losse H, Vetter H, Epstein FH, Vetter W (1985) Compliance with salt restriction as a limiting factor in the primary prevention of hypertension. J Hypertens 3 [Suppl 1]: 87Google Scholar
  30. 30.
    O’Brian Smith E, Curb JD, Hardy RJ, Hawkins CM, Tyroler HA (1982) Clinic attendance in the hypertension detection and follow-up program. Hypertension 4:710CrossRefGoogle Scholar
  31. 31.
    Perry HM Jr, Camel GH (1984) Survival of treated hypertensive patients as a function of compliance and control. J Hypertens 2 [Suppl 3]: 197Google Scholar
  32. 32.
    Perry HM Jr, Meyer G, Freis E, Neal W, Ramirez E, Schnapper H, Thomas JR, Carmody S (1986) Six-year compliance with a treatment regimen and resultant control of blood pressure in special Veterans Administration Hypertension Clinics. J Hypertens 4 [Suppl 5]: 393Google Scholar
  33. 33.
    Ruomilehto J, Enlund H, Salonen JT, Nissinan A (1984) Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 12:177Google Scholar
  34. 34.
    Steiner R, Lüscher T, Boerlin H-J, Siegenthaler W, Vetter W (1985) Clinical evaluation of semiautomatic blood pressure devices for self-recording. J Hypertens 3 [Suppl 1]:23Google Scholar
  35. 35.
    Veterans Administration Cooperative Study Group (1967) Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202:1028CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • T. F. Lüscher
    • 1
  1. 1.Departement für Innere Medizin, Abteilung für KardiologieKantonsspitalBaselSchweiz

Personalised recommendations